| Neck Neoplasm studied in …STUDIED_INderived10 of 2,377show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped CURATED_BROADER · 2,377 trials mapped (843 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 2,377 trials mapped (843 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06309225NA · recruiting Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly · condition mapped ALIAS · 2,377 trials mapped (843 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 2,377 trials mapped (843 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06589804Phase 3 · recruiting Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment · condition mapped CURATED_BROADER · 2,377 trials mapped (843 active) | — | — | Hypopharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991738Phase 1/Phase 2 · not yet recruiting 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer · condition mapped CURATED_EXACT · 2,377 trials mapped (843 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195734Phase 2 · recruiting Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 2,377 trials mapped (843 active) | — | — | Malignant Laryngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 2,377 trials mapped (843 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03429036recruiting Biospecimen Procurement for Head and Neck Disorders · condition mapped ONTOLOGY_EXACT · 2,377 trials mapped (843 active) | — | — | Pharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03644563active not recruiting Men and Women Offering Understanding of Throat HPV · condition mapped CURATED_EXACT · 2,377 trials mapped (843 active) | — | — | Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |